Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

The Potential Utility of Cerebral Fluid sLR11 and sIL-2R As a Marker for CNS Involvement of Malignant Lymphoma

Naomi Shimizu, Sanshiro Nakao, Chiaki Nakaseko, Tomo Shimizu, Hiroyuki Ebinuma, Hideaki Bujo

Blood (2023) 142 (Supplement 1): 6128.

https://doi.org/10.1182/blood-2023-174611

Published: 2023

Journal Articles

Rituximab (R)-CHOP Therapy Has Progressed Arteriosclerosis with an Elevation of Von Willebrand Factor (vWF) in Patients with Malignant Lymphoma

Naomi Shimizu, MD, Shouko Nakamura, MD, Naoyuki Kawagoe, MD PhD, Rena Oka, MD PhD, Yasuhiro Watanabe, MD PhD, Sho Tanaka, MD, Yuta Sato, MD PhD, Takashi Yamaguchi, MD PhD, Masahiro Ohira, MD PhD, Atsuhito Saiki, MD PhD, Chiaki Nakaseko, MD PhD, Emiko Sakaida, MD PhD, Hideaki Bujo, MD PhD, Kohji Shirai, MD PhD, Ichiro Tatsuno, MD PhD

Blood (2018) 132 (Supplement 1): 5380.

https://doi.org/10.1182/blood-2018-99-112326

Published: 2018

Journal Articles

Elevation of Cardio-Ankle Vascular Index in Patients with Malignant Lymphoma Treated with R-CHOP Regimen

Naomi Shimizu, MD PhD, Yasuhiro Watanabe, MD, Shouko Nakamura, MD, Sho Tanaka, MD, Rena Oka, MD, Yuta Sato, MD PhD, Haruki Imamura, MD PhD, Takashi Yamaguchi, MD PhD, Chiaki Nakaseko, MDPhD, Emiko Sakaida, MD PhD, Hideaki Bujo, MD PhD, Kohji Shirai, MD PhD, Ichiro Tatsuno, MD PhD

Blood (2017) 130 (Supplement 1): 5151.

https://doi.org/10.1182/blood.V130.Suppl_1.5151.5151

Published: 2017

Journal Articles

Oxidative Stress Levels Are Correlated with Disease Progression and Iron Overload in MDS Patients with Excess Blasts

Naomi Shimizu, MD PhD, Yasuhiro Watanabe, MD, Noriko Ban, MD PhD, Takashi Yamaguchi, MD PhD, Hidekazu Hasunuma, Youichi Iwashita, Hiromitsu Yokota, Chiaki Nakaseko, MD PhD, Hideaki Bujo, MD PhD, Ichiro Tatsuno, MD PhD

Blood (2016) 128 (22): 5532.

https://doi.org/10.1182/blood.V128.22.5532.5532

Published: 2016

Journal Articles

Soluble LR11, GCSF−induced Migration Regulator from Myeloid Cells, Is Highly Increased in Chronic Myeloid Leukemia

Naomi Shimizu, MD PhD, Hideaki Bujo, MD PhD, Meizi Jiang, MD PhD, Keigo Nishii, Emiko Sakaida, MD PhD, Chikako Ohwada, MD PhD, Masahiro Takeuchi, MD PhD, Naoya Mimura, MD PhD, Yusuke Takeda, MD PhD, Shokichi Tsukamoto, MD PhD, Tomoya Muto, MD PhD, Ichiro Tatsuno, MD PhD, Chiaki Nakaseko, MD PhD

Blood (2014) 124 (21): 4961.

https://doi.org/10.1182/blood.V124.21.4961.4961

Published: 2014

Journal Articles

Impact of Serum Soluble LR11 on Survival in Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Multicenter Prospective Study

Blood (2014) 124 (21): 1661.

https://doi.org/10.1182/blood.V124.21.1661.1661

Published: 2014

Journal Articles

Tetraspanin CD9 Inhibits ADAM17-Mediated LR11 Shedding In Leukemia Cells

Shokichi Tsukamoto, MD, Masahiro Takeuchi, MD, PhD, Takeharu Kawaguchi, MD, PhD, Emi Togasaki, MD, Atsuko Yamazaki, MD, Yasumasa Sugita, MD, Tomoya Muto, MD, PhD, Shio Sakai, MD, PhD, Yusuke Takeda, MD, PhD, Chikako Ohwada, MD, PhD, Naomi Shimizu, MD, PhD, Emiko Sakaida, MD, PhD, Keigo Nishii, Meizi Jiang, MD, PhD, Tohru Iseki, MD, PhD, Koutaro Yokote, MD, PhD, Hideaki Bujo, MD, PhD, Chiaki Nakaseko, M.D., Ph.D.

Blood (2013) 122 (21): 1035.

https://doi.org/10.1182/blood.V122.21.1035.1035

Published: 2013

Journal Articles

Serum Soluble LR11 Can Predict High FLIPI-2 Score in Follicular Lymphoma.

Takeharu Kawaguchi, MD, Chikako Ohwada, MD, PhD, Naomi Shimizu, MD, PhD, Masahiro Takeuchi, MD, PhD, Emiko Sakaida, M.D., PhD., Yusuke Takeda, M.D., PhD., Shio Sakai, MD, PhD, Shokichi Tsukamoto, MD, Atsuko Yamazaki, MD, Morihiro Higashi, M.D., PhD., Jun-Ichi Tamaru, M.D., PhD., Kotaro Yokote, M.D., PhD., Hideaki Bujo, MD, PhD, Chiaki Nakaseko, MD, PhD

Blood (2012) 120 (21): 2673.

https://doi.org/10.1182/blood.V120.21.2673.2673

Published: 2012

Journal Articles

Soluble LR11, a Novel Acute Leukemia Marker, Drastically Induces WT1 mRNA Expression Together with Synergic Activation of Gatas, and the Migration Activity

Naomi Shimizu, MD, PhD, Chiaki Nakaseko, MD, PhD, Masahiro Takeuchi, MD, PhD, Chikako Ohwada, MD, PhD, Shokichi Tsukamoto, MD, Takeharu Kawaguchi, MD, Shio Sakai, MD, PhD, Atsuko Yamazaki, MD, Keigo Nishii, Meiji Jiang, Koutaro Yokote, MD, PhD, Hideaki Bujo, MD, PhD

Blood (2012) 120 (21): 4795.

https://doi.org/10.1182/blood.V120.21.4795.4795

Published: 2012

Journal Articles

LR11 Is a Potential Serum and Histological Biomarker for Intravascular Large B-Cell Lymphoma

Chikako Ohwada, MD, PhD, Takeharu Kawaguchi, MD, Naomi Shimizu, MD, PhD, Masahiro Takeuchi, MD, PhD, Emiko Sakaida, M.D., PhD., Yusuke Takeda, M.D., PhD., Kazuhisa Fujikawa, MD, PhD, Kosei Matsue, MD, PhD, Morihiro Higashi, M.D., PhD., Jun-Ichi Tamaru, M.D., PhD., Kotaro Yokote, M.D., PhD., Hideaki Bujo, MD, PhD, Chiaki Nakaseko, MD, PhD

Blood (2012) 120 (21): 5104.

https://doi.org/10.1182/blood.V120.21.5104.5104

Published: 2012

Journal Articles

LR11 Plays a Critical Role in Leukemogenesis of Acute Myeloid Leukemia by Regulating Adhesion and Homing Ability to Bone Marrow.

Keigo Nishii, Chiaki Nakaseko, MD, PhD, Masahiro Takeuchi, MD, PhD, Naomi Shimizu, MD, PhD, Chikako Ohwada, MD, PhD, Shokichi Tsukamoto, MD, Takeharu Kawaguchi, MD, Atsuko Yamazaki, MD, Meiji Jiang, Atsushi Iwama, MD, PhD, Hideaki Bujo, MD, PhD

Blood (2012) 120 (21): 2409.

https://doi.org/10.1182/blood.V120.21.2409.2409

Published: 2012

Journal Articles

Soluble LR11/SorLA, a Potential Circulating Marker Indicating the G-CSF-Induced Mobilization of Hematopoietic Stem Cells, Is a Modulator of G-CSF-Mediated Migration of HL-60 Cells,

Naomi Shimizu, MD, PhD, Chiaki Nakaseko, MD, PhD, Masahiro Takeuchi, MD, PhD, Chikako Ohwada, MD, PhD., Shokichi Tsukamoto, MD, Takeharu Kawaguchi, MD, Keigo Nishii, Meiji Jiang, Koutaro Yokote, MD, PhD, Isamu Fukamachi, Hideaki Bujo, MD, PhD

Blood (2011) 118 (21): 3210.

https://doi.org/10.1182/blood.V118.21.3210.3210

Published: 2011

Journal Articles

Serum Soluble LR11 As a Novel Biomarker for B Cell Lymphoma

Takeharu Kawaguchi, M.D., Chikako Ohwada, MD, PhD., Morihiro Higashi, M.D., PhD., Masahiro Takeuchi, MD, PhD, Shio Sakai, M.D., PhD., Yusuke Takeda, M.D., PhD., Naomi Shimizu, MD, PhD, Emiko Sakaida, M.D., PhD., Kohei Takubo, PhD., Hiroyuki Ebinuma, PhD., Isamu Fukamachi, PhD., Jun-Ichi Tamaru, M.D., PhD., Koutaro Yokote, MD, PhD, Hideaki Bujo, MD, PhD, Chiaki Nakaseko, MD, PhD

Blood (2011) 118 (21): 1581.

https://doi.org/10.1182/blood.V118.21.1581.1581

Published: 2011

Journal Articles

LR11 Is a Novel Surface Marker for Normal Leukocytes and Leukemia Cells

Masahiro Takeuchi, M.D., PhD., Chikako Ohwada, M.D., PhD., Shio Sakai, M.D., Yusuke Takeda, M.D., PhD., Daijiro Abe, M.D., PhD., Naomi Shimizu, M.D., PhD., Emiko Sakaida, M.D., PhD., Takeharu Kawaguchi, M.D., Kohei Takubo, PhD., Hiroyuki Ebinuma, PhD., Isamu Fukamachi, PhD., Koutaro Yokote, M.D., PhD., Atsushi Iwama, M.D., PhD., Wolfgang J Schneider, PhD., Hideaki Bujo, M.D., PhD., Chiaki Nakaseko, M.D., PhD.

Blood (2010) 116 (21): 4834.

https://doi.org/10.1182/blood.V116.21.4834.4834

Published: 2010

Journal Articles

Prognostic Impact of a Novel Biomarker, Serum Soluble LR11 on Acute Leukemia

Chikako Ohwada, M.D., PhD., Masahiro Takeuchi, M.D., PhD., Shio Sakai, M.D., Daijiro Abe, M.D., PhD., Yusuke Takeda, M.D., PhD., Naomi Shimizu, M.D., PhD., Emiko Sakaida, M.D., PhD., Takeharu Kawaguchi, M.D., Kohei Takubo, PhD., Hiroyuki Ebinuma, PhD., Isamu Fukamachi, PhD., Koutaro Yokote, M.D., PhD., Atsushi Iwama, M.D., PhD., Wolfgang J Schneider, PhD, Hideaki Bujo, M.D., PhD., Chiaki Nakaseko, M.D., PhD.

Blood (2010) 116 (21): 2717.

https://doi.org/10.1182/blood.V116.21.2717.2717

Published: 2010

NARROW

The Potential Utility of Cerebral Fluid sLR11 and sIL-2R As a Marker for CNS Involvement of Malignant Lymphoma

Rituximab (R)-CHOP Therapy Has Progressed Arteriosclerosis with an Elevation of Von Willebrand Factor (vWF) in Patients with Malignant Lymphoma

Elevation of Cardio-Ankle Vascular Index in Patients with Malignant Lymphoma Treated with R-CHOP Regimen

Oxidative Stress Levels Are Correlated with Disease Progression and Iron Overload in MDS Patients with Excess Blasts

Soluble LR11, GCSF−induced Migration Regulator from Myeloid Cells, Is Highly Increased in Chronic Myeloid Leukemia

Impact of Serum Soluble LR11 on Survival in Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Multicenter Prospective Study

Tetraspanin CD9 Inhibits ADAM17-Mediated LR11 Shedding In Leukemia Cells

Serum Soluble LR11 Can Predict High FLIPI-2 Score in Follicular Lymphoma.

Soluble LR11, a Novel Acute Leukemia Marker, Drastically Induces WT1 mRNA Expression Together with Synergic Activation of Gatas, and the Migration Activity

LR11 Is a Potential Serum and Histological Biomarker for Intravascular Large B-Cell Lymphoma

LR11 Plays a Critical Role in Leukemogenesis of Acute Myeloid Leukemia by Regulating Adhesion and Homing Ability to Bone Marrow.

Soluble LR11/SorLA, a Potential Circulating Marker Indicating the G-CSF-Induced Mobilization of Hematopoietic Stem Cells, Is a Modulator of G-CSF-Mediated Migration of HL-60 Cells,

Serum Soluble LR11 As a Novel Biomarker for B Cell Lymphoma

LR11 Is a Novel Surface Marker for Normal Leukocytes and Leukemia Cells

Prognostic Impact of a Novel Biomarker, Serum Soluble LR11 on Acute Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only